# Progress Note 07 — Annual Wellness Visit, Subsequent

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jesse Owens (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML042-SYN-TD
- Date: 1979-10-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Clarence Whitfield-Arroyo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Annual Wellness Visit, Subsequent
- Services: HCPCS G0439 (subsequent annual wellness visit) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Subsequent annual wellness visit; no new complaints. **S**

## History of present illness

Mr. Owens, now 66, returns for his subsequent annual wellness visit three weeks after his post-operative review; his last wellness visit was at his previous clinic a year ago. He is nine weeks past a thoracoscopic left upper lobectomy, after three cycles of chemoimmunotherapy, and has had no further cancer treatment since. He goes to pulmonary rehabilitation twice a week and walks 2.5 km most mornings. He has not smoked for four and a half months and takes varenicline 1 mg twice daily without side effects. He has gone back to speaking at two schools. He completed the health risk assessment beforehand and asked to talk about what he would want if the cancer came back. **S**

| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit, age 66 |
| Active conditions | Left upper lobe adenocarcinoma, treated with chemoimmunotherapy and lobectomy (ypT1a N0, R0), now under surveillance; nicotine dependence in early remission on varenicline |
| Medicines | Varenicline 1 mg twice daily; no over-the-counter medicines or supplements |
| Safety events | No falls; no emergency visits since the operation |
| Functional status | Independent in all activities and instrumental activities of daily living |

## Health risk assessment

Completed by the patient on paper in the waiting room and reviewed with him by Dr. Whitfield-Arroyo. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and getting better |
| Psychosocial | Lives with his wife; daughters call often; church and youth work; worries about the cancer returning, but sleeps well |
| Tobacco | No cigarettes for four and a half months, after 35 years at a pack a day; no vaping |
| Alcohol and drugs | A beer or a glass of wine once or twice a week (AUDIT-C 2); no drugs |
| Physical activity | Walks 2.5 km most mornings and attends pulmonary rehabilitation twice a week |
| Nutrition | Eats regular meals; weight steady since the operation |
| Activities of daily living | Independent in bathing, dressing, eating, toileting and transfers |
| Instrumental activities of daily living | Drives, manages his business, his medicines and his money |
| Home safety | Smoke detectors working; no loose rugs; grab bar in the shower |
| Hearing and vision | Hears well; reading glasses; eye examination two years ago |
| Sun and heat | Walks before the heat of the day and carries water |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; energy returning |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | No hoarseness or hearing loss |
| Cardiovascular | Negative | No chest pain, palpitations or leg swelling |
| Respiratory | Positive | Mild breathlessness on two flights of stairs, improving with rehabilitation; no cough or hemoptysis |
| Gastrointestinal | Negative | No change in bowel habit or black stools |
| Genitourinary | Negative | No urinary symptoms; no blood in the urine |
| Musculoskeletal | Positive | Occasional aching along the left chest wall at the port sites; no bone pain |
| Integumentary | Negative | No rash; incisions healed |
| Neurological | Negative | No numbness, headaches or weakness |
| Psychiatric | Negative | Mood good; PHQ-2 0; no thoughts of self-harm |
| Endocrine | Negative | No heat or cold intolerance |

12 systems reviewed. **S**

## Current medications

- Varenicline 1 mg oral tablet, one tablet by mouth twice daily after food, for 12 weeks and then a further 12 weeks to prevent relapse **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/76 mmHg; pulse 70 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 96% on room air; weight 75 kg; BMI 23.7 kg/m². All vital signs are synthetic.

PHQ-2: 0; Mini-Cog: 5; AUDIT-C: 2. All results are synthetic.

## Change since baseline

- PHQ-2: 1 at baseline, 0 at this visit **S**

## Immunizations given today

- Influenza vaccine, high-dose, this season **S**
- COVID-19 mRNA vaccine, this season's formula **S**
- Respiratory syncytial virus vaccine, single dose **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well and upright; weight 75.0 kg, BMI 23.7; blood pressure 124/76, pulse 70 |
| Eyes | Near vision 20/30 with reading glasses |
| Ears | Whispered-voice test passed on both sides |
| Neck | No lymph nodes; thyroid not enlarged |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Breath sounds slightly reduced at the left apex after the lobectomy; no crackles or wheeze; healed thoracoscopic incisions |
| Musculoskeletal | Timed Up and Go 9 seconds; rises from a chair without using his arms |
| Neurological | Oriented; Mini-Cog 5 of 5; normal gait |
| Skin | No suspicious lesions |
| Psychiatric | Calm, engaged and good-humored |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Subsequent annual wellness visit completed**. Health risk assessment reviewed, personalized prevention plan updated and a written copy given. Depression, alcohol, cognitive and fall-risk screens are negative. **S**
   - Next annual wellness visit in one year.
2. **Left upper lobe adenocarcinoma after chemoimmunotherapy and lobectomy, under surveillance** (C34.12). No symptoms of recurrence; recovering well with rehabilitation. Yearly low-dose screening CT is replaced by surveillance CT every six months for two to three years. **S**
   - Surveillance CT of the chest in about five months, as booked.
   - Continue pulmonary rehabilitation to the end of the program.
3. **Nicotine dependence in early remission** (F17.211). Four and a half months without smoking; varenicline to complete 24 weeks next month. **S**
   - Continue varenicline to complete 24 weeks, then stop.
   - Quitline relapse-prevention calls continue.
4. **Cardiovascular risk**. Moderate coronary artery calcification on the screening CT and 35 years of smoking put him at raised risk; no angina. A statin is likely to be recommended once the lipid panel is back. **S**
   - Fasting lipid panel and hemoglobin A1c ordered.
   - Discuss a moderate-intensity statin at the next visit.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Lung cancer screening | Not indicated | Replaced by surveillance CT after treatment for lung cancer; yearly low-dose CT resumes after the surveillance period |
| Tobacco cessation | Completed today | Abstinent four and a half months; varenicline and quitline support continue |
| Abdominal aortic aneurysm screening | Up to date | One-time screening for men 65 to 75 who have smoked: the infrarenal aorta measured 2.1 cm on the staging CT, normal |
| Colorectal cancer screening | Up to date | Normal colonoscopy four years ago; next in six years |
| Prostate cancer screening | Not indicated | Discussed; at 66, with a cancer under surveillance, he chose not to have a PSA test |
| Hepatitis C screening | Up to date | Negative before chemoimmunotherapy |
| Lipid panel and statin assessment | Ordered | Coronary calcification on CT; fasting lipid panel and A1c ordered |
| Blood pressure screening | Completed today | 124/76 mmHg |
| Depression screening | Completed today | PHQ-2 score 0 |
| Alcohol misuse screening | Completed today | AUDIT-C score 2 |
| Cognitive assessment | Completed today | Mini-Cog 5 of 5 |
| Falls prevention | Completed today | Timed Up and Go 9 seconds; no falls |
| Influenza vaccine | Completed today | High-dose vaccine given |
| COVID-19 vaccine | Completed today | This season's vaccine given |
| RSV vaccine | Completed today | Single dose for an adult 60 to 74 at increased risk |
| Recombinant zoster vaccine | Completed today | Dose 1 today; dose 2 in two to six months |
| Pneumococcal vaccine | Up to date | PCV20 before chemoimmunotherapy |
| Tetanus, diphtheria, and pertussis | Due | No record of a booster in ten years; Tdap with the second zoster dose |

## Advance care planning

Voluntary advance care planning discussion of about 25 minutes, with his consent. He named a health care agent, recorded in the confidential part of the chart and not named here, and completed an Arizona health care power of attorney. He wants every treatment that offers a real chance of controlling the cancer if it comes back, including more surgery, radiation or medicines. If the cancer returned and could no longer be controlled, he would want his symptoms treated well and to stay at home, with his family and his church, rather than spend his last weeks in intensive care, and he would not want resuscitation in that situation. He wants his story told to young people so that they never start smoking. To be revisited at any change in his health and at least yearly. **S**

## Guideline basis

- US Preventive Services Task Force. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021;325(10):962-970 (PMID 33687470) (2021), U.S. Preventive Services Task Force
- Medicare Wellness Visits (Medicare Learning Network) (2026), Centers for Medicare & Medicaid Services
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Lipid panel and A1c this week. Second zoster dose and Tdap in two to six months. Surveillance CT as booked. Next annual wellness visit in one year. **S**

